NCT07376655 Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life
| NCT ID | NCT07376655 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yale University |
| Condition | Diabetes Type 2 |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-06-04 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-06-04 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goals of this randomized trial is to learn: 1. If the Thrive AI Health app will help adults improve their everyday habits (diet, exercise, and sleep). 2. How often participants will use the Thrive AI Health app to which they will have free access The Thrive AI Health app uses artificial intelligence (AI) to give personalized advice. It is designed to help people eat better, exercise more, manage stress, and sleep well. Researchers will compare changes in diet, exercise and sleep in participants using the app to those participants not using the app. Participants will complete study questionnaires and an in-person visit at the beginning and end of the study.
Eligibility Criteria
Inclusion Criteria: * Be at high risk for chronic disease defined as: Body mass index (BMI)\>25 BMI\<=25 who are prediabetic or have type 2 diabetes * Aged 40 years or older Exclusion Criteria: * Unable to walk
Contact & Investigator
Melinda Irwin
PRINCIPAL INVESTIGATOR
Yale University
Frequently Asked Questions
Who can join the NCT07376655 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Diabetes Type 2. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07376655 currently recruiting?
Yes, NCT07376655 is actively recruiting participants. Contact the research team at melinda.irwin@yale.edu for enrollment information.
Where is the NCT07376655 trial being conducted?
This trial is being conducted at New Haven, United States.
Who is sponsoring the NCT07376655 clinical trial?
NCT07376655 is sponsored by Yale University. The principal investigator is Melinda Irwin at Yale University. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.